基本信息
views: 1
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
I'm Yuan Ma, a postdoc researcher from University of Illinois at Urbana-Champaign, USA. My research interests including cancer therapy, drug delivery, cancer theranostics, nanomaterial, DNA nanotechnology, functional DNA (eg. aptamer, DNAzyme), aptamer SELEX and application, analytical chemistry, point of care sensor.
Research Interests
Papers共 47 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
RSC medicinal chemistryno. 5 (2024): 1782-1782
Drug Metabolism and Pharmacokinetics Pharmaceutical Science (2024)
Yuan Ma,Huarui Zhang,Xinyang Shen, Xin Yang, Yan Deng, Yuan Tian,Zefeng Chen,Yufei Pan,Hang Luo,Chuanxin Zhong,Sifan Yu,Aiping Lu,
Cancer Letters (2024): 217102-217102
Amu Gubu,Yuan Ma,Sifan Yu,Huarui Zhang,Zefeng Chen,Shuaijian Ni, Razack Abdullah,Huan Xiao,Yihao Zhang,Hong Dai,Hang Luo,Yuanyuan Yu,
MOLECULAR THERAPY NUCLEIC ACIDSno. 1 (2024): 102146-102146
Tao Xiaohui,Luyao Wang, Xin Yang,Hewen Jiang,Ning Zhang,Huarui Zhang,Dijie Li, Xiaofei Li,Yihao Zhang,Shenghang Wang,Chuanxin Zhong,Sifan Yu,
Journal of Orthopaedic Translation (2024): 39-49
RSC medicinal chemistryno. 5 (2024): 1515-1526
Shijian Ding, Xin Yang, Chi Ho Chan,Yuan Ma,Sifan Yu,Luyao Wang,Aiping Lyu,Baoting Zhang,Yuanyuan Yu,Ge Zhang
crossref(2024)
Yufei Pan,Yuejie Zhu,Yuan Ma, Jiamei Hong,Wenting Zhao,Yujing Gao, Jing Guan,Runan Ren,Qi Zhang,Jing Yu,Zhu Guan,Zhenjun Yang
Biomedicine & Pharmacotherapy (2024): 116239-116239
RSC MEDICINAL CHEMISTRY (2024)
Nature Biotechnologyno. 4 (2023): 1-9
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn